A FIRST IN HUMAN TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF SARS-CoV-2 UQSC2 VACCINE IN HEALTHY ADULTS.
Clinical trial NCT05775887 · COMPLETED
Trial details
- NCT number
- NCT05775887
- Sponsor
- The University of Queensland
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-08
- Primary completion
- 2023-12-02
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.